CoChat

Whole exome sequencing of relapsed/refractory patients expands the repertoire of somatic mutations in diffuse large B‐cell lymphoma

Mareschal, Sylvain, Dubois, Sydney, Viailly, Pierre‐Julien, Bertrand, Philippe, Bohers, Elodie, Maingonnat, Catherine, Jaïs, Jean‐Philippe, Tesson, Bruno, Ruminy, Philippe, Peyrouze, Pauline, Copie‐Bergman, Christiane, Fest, Thierry, Jo Molina, Thierry, Haioun, Corinne, Salles, Gilles, Tilly, Hervé, Lecroq, Thierry, Leroy, Karen, Jardin, Fabrice · 2016 · Genes, Chromosomes and Cancer
Cited by 89

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Despite the many efforts already spent to enumerate somatic mutations in diffuse large B‐cell lymphoma (DLBCL), previous whole‐genome and whole‐exome studies conducted on patients of mixed outcomes failed at characterizing the 30% of patients who will relapse or resist current immunochemotherapies. To address this issue, we performed whole‐exome sequencing of normal/tumoral DNA pairs in 14 relapsed/refractory (R/R) patients subclassified by full‐transcriptome arrays (six activated B‐cell like, three germinal center B‐cell like, and five primary mediastinal B‐cell lymphomas), from the LNH‐03 LYSA clinical trial program. Aside from well‐known DLBCL features, gene and pathway level recurrence analyses proposed several interesting leads including TBL1XR1 and activating mutations in IRF4 or in the insulin regulation pathway. Sequencing‐based copy number analysis defined 23 short recurrently altered regions involving genes such as REL, CDKN2A, HYAL2, and TP53. Moreover, it highlighted mutations in genes such as GNA13, CARD11, MFHAS1, and PCLO as associated with secondary variant allele amplification events. The five primary mediastinal B‐cell lymphomas (PMBL), while unexpected in a R/R cohort, showed a significantly higher mutation rate (P = 0.003) and provided many insights on this classical Hodgkin lymphoma related subtype. Novel genes such as XPO1, MFHAS1, and ITPKB were found particularly mutated, along with various cytokine‐based signaling pathways. Among these analyses, somatic events in the NF‐κB pathway were found preponderant in the three DLBCL subtypes, confirming its major implication in DLBCL aggressiveness and pinpointing several new candidate genes. © 2015 Wiley Periodicals, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/gcc.22328

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 89

Metadata

Authors
Mareschal, S., Dubois, S., Viailly, P., Bertrand, P., Bohers, E., Maingonnat, C., Jaïs, J., Tesson, B., Ruminy, P., Peyrouze, P., Copie‐Bergman, C., Fest, T., Jo Molina, T., Haioun, C., Salles, G., Tilly, H., Lecroq, T., Leroy, K., & Jardin, F.
Venue
Genes, Chromosomes and Cancer
Publisher
Wiley
Published
2015-11-26
Volume
55
Issue
3
Pages
251-267
ISSN
  • 1045-2257 (ISSN-L)
  • 1098-2264
OpenAlex
W2178959886
Cited by
89
References
4
FWCI
9.41
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Whole exome sequencing of relapsed/refractory patients expands the repertoire of somatic mutations in diffuse large B‐cell lymphoma. https://app.cochat.ai/papers/10.1002/gcc.22328
The paper
Mareschal, S., Dubois, S., Viailly, P., Bertrand, P., Bohers, E., Maingonnat, C., Jaïs, J., Tesson, B., Ruminy, P., Peyrouze, P., Copie‐Bergman, C., Fest, T., Jo Molina, T., Haioun, C., Salles, G., Tilly, H., Lecroq, T., Leroy, K., & Jardin, F. (2016). Whole exome sequencing of relapsed/refractory patients expands the repertoire of somatic mutations in diffuse large B‐cell lymphoma. Genes, Chromosomes and Cancer. https://doi.org/10.1002/gcc.22328

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.